首页 正文

Milvexian: An Oral, Bioavailable Factor XIa Inhibitor

{{output}}
Direct oral anticoagulants have a dose-dependent increased bleeding risk which limits use in certain populations. Studies in both animals and humans with inherited variations in factor XI levels provide a theoretical basis for a drug target capable of addressi... ...